Pfizer (NYSE:PFE) recently announced positive topline results from its Phase 3 BASIS study for HYMPAVZI™ and declared a third-quarter 2025 dividend of $0.43 per share. Alongside these developments, ...

Pfizer will pay a $0.43 quarterly dividend on September 2, 2025, maintaining its 347-quarter streak of shareholder payouts.

Pfizer's revenue slump is temporary. New launches and Seagen integration drive 2025 growth. Read here for an investment ...

The world of investing involves uncertainty, volatility, and ever-changing macroeconomic conditions. In such scenarios, ...

Safe dividend-paying income stocks trading under $30 are passive income home runs. Stocks trading under the $30 level offer Boomers a larger share count when they buy. With the geopolitical ...

With continued uncertainty over Washington's policy priorities plus a recent flare-up of geopolitical tensions in the Middle East, it seems like Wall Street may continue to focus on ...

There is perhaps no better way to put a $500,000 windfall to work than to stash it in a self-directed investment portfolio.

Pfizer Inc. (NYSE:PFE) is one of the Best Dividend Leaders to Buy Now. The company’s strategy focuses on steadily increasing ...

Pfizer’s Q1 earnings call delivered a rollercoaster of cautious optimism. CEO Albert Bourla credited solid execution in ...

For this list, we're looking at U.S. stocks only that trade on major exchanges, with market caps of at least $10 billion. The ...

Manulife Philippines has partnered with Pfizer to promote disease awareness and patient education, as part of its Better Days ...

The launch of the FIBRE Consortium, which includes Lantheus Holdings (NasdaqGM:LNTH) collaborating with Pfizer and Lumina Pharmaceuticals, aims to improve treatment for fibrotic diseases using ...